Optimising radiotherapy of liver tumours: radiobiology of yttrium-90 microsphere treatment
<p><strong>Background:</strong> Yttrium-90 selective internal radiotherapy (90Y SIRT) is a treatment aimed at improving tumour control within the liver, from which the disease burden is the most common cause of death. FOXFIRE, SIRFLOX, SARAH and other phase 3 clinical trials of SIR...
Autor principal: | Abbott, EM |
---|---|
Altres autors: | Vallis, K |
Format: | Thesis |
Idioma: | English |
Publicat: |
2019
|
Matèries: |
Ítems similars
-
Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer
per: Yasaman Anbari, et al.
Publicat: (2023-11-01) -
Yttrium-90 selective internal radiation therapy on liver cancer: the past, the present, and the future
per: Jingqin MA, et al.
Publicat: (2025-02-01) -
Application progress of Yttrium-90 microsphere selective internal radiation therapy on metastatic liver cancer
per: Guanxiang ZHUO, et al.
Publicat: (2025-02-01) -
Successful treatment with yttrium-90 microspheres in a metastatic breast cancer patient and sclerosing cholangitis
per: Aurélie Louvet, et al.
Publicat: (2021-08-01) -
A Clinical Trial of The Evaluation of Environmental Exposure in Yttrium 90 Radioembolization
per: Handan Tanyildizi, et al.
Publicat: (2018-12-01)